While the expression levels of KRAS did not differ between proliferative (n = 21) and secretory phase (n = 44), the levels of KRAS were significantly higher in the endometrium that originated in subjects with endometriosis (n = 54) as compared to controls (n = 11) (Fig. 2a and b). Here, KRAS is linked to endometriosis.